Naproxeno Sódico Kern Pharma (Naproxen Sodium)

Naproxen sodium blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, it diminishes the signals that cause pain, swelling, and fever.

The appropriate dose is determined by the prescribing clinician based on the individual’s condition, age, weight, and response to therapy. Typical adult regimens may start with a loading dose followed by maintenance dosing, but exact amounts should follow the prescriber’s instructions.

Safety data for naproxen sodium in pregnancy and lactation are limited. It is generally advised to avoid use during the third trimester and to weigh potential benefits against risks in earlier stages. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both naproxen sodium and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a quicker onset. Choice between them depends on clinical response, dosing convenience and individual safety considerations.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food or milk may reduce gastrointestinal irritation.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, and severe skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Individuals with known hypersensitivity to naproxen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal impairment should avoid naproxen sodium unless specifically directed by a healthcare professional.